Page last updated: 2024-10-24

carprofen and Infections, Coronavirus

carprofen has been researched along with Infections, Coronavirus in 1 studies

carprofen: RN given refers to cpd without isomeric designation
carprofen : Propanoic acid in which one of the methylene hydrogens is substituted by a 6-chloro-9H-carbazol-2-yl group. A non-steroidal anti-inflammatory drug, it is no longer used in human medicine but is still used for treatment of arthritis in elderly dogs.

Research Excerpts

ExcerptRelevanceReference
"Carprofen and Celecoxib have been selected by the COVID Moonshot initiative for in vitro testing; they show 3."1.56Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition. ( Cereto-Massagué, A; Garcia-Vallvé, S; Gimeno, A; Macip, G; Mestres-Truyol, J; Ojeda-Montes, MJ; Pujadas, G; Saldivar-Espinoza, B, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Gimeno, A1
Mestres-Truyol, J1
Ojeda-Montes, MJ1
Macip, G1
Saldivar-Espinoza, B1
Cereto-Massagué, A1
Pujadas, G1
Garcia-Vallvé, S1

Other Studies

1 other study available for carprofen and Infections, Coronavirus

ArticleYear
Prediction of Novel Inhibitors of the Main Protease (M-pro) of SARS-CoV-2 through Consensus Docking and Drug Reposition.
    International journal of molecular sciences, 2020, May-27, Volume: 21, Issue:11

    Topics: Antiviral Agents; Betacoronavirus; Binding Sites; Carbazoles; Celecoxib; Coronavirus Infections; COV

2020